These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16809036)
1. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors. Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036 [TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Selective inhibition of human tumor-associated isozymes IX and XII and cytosolic isozymes I and II with some substituted-2-mercapto-benzenesulfonamides. Saczewski F; Innocenti A; Brzozowski Z; Slawiński J; Pomarnacka E; Kornicka A; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2006 Oct; 21(5):563-8. PubMed ID: 17194028 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives. Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII. Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384 [TBL] [Abstract][Full Text] [Related]
10. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. Brzozowski Z; Sławiński J; Innocenti A; Supuran CT Eur J Med Chem; 2010 Sep; 45(9):3656-61. PubMed ID: 20554082 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. Stiti M; Cecchi A; Rami M; Abdaoui M; Barragan-Montero V; Scozzafava A; Guari Y; Winum JY; Supuran CT J Am Chem Soc; 2008 Dec; 130(48):16130-1. PubMed ID: 18989963 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides. Smaine FZ; Winum JY; Montero JL; Regainia Z; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2007 Sep; 17(18):5096-100. PubMed ID: 17646100 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. Brzozowski Z; Sławiński J; Vullo D; Supuran CT Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides. Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. Innocenti A; Vullo D; Pastorek J; Scozzafava A; Pastorekova S; Nishimori I; Supuran CT Bioorg Med Chem Lett; 2007 Mar; 17(6):1532-7. PubMed ID: 17257840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]